Raymond James Financial Services Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,039	Closed	-$162K	–	3431
2024 Q1	$162K	Buy	+22,039	New	+$162K	﹤0.01%	3144
2021 Q2	–	Sell	-3,983	Closed	-$328K	–	3260
2021 Q1	$328K	Buy	3,983 +43	+1%	+$3.54K	﹤0.01%	2564
2020 Q4	$358K	Buy	+3,940	New	+$358K	﹤0.01%	2348